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Dermal cells are capable of initiating contact-hyper-
sensitivity responses bnt the precise identification of 
the antigen-presenting cell within murine dermis is 
lacking. Class II major histocompatibility complex 
(MHC)+ cells with dendritic shape and lacking endo-
thelial factor VIII but expressing the dendritic anti-
gen-presenting cell marker NLDC-145 were observed 
in the perivascular and interstitial dermis of BALB / c 
and C3H/ HeN skin. The heterogeneous class II MHC+ 
cells could be divided into two subsets: each was class II 
MHC+ CD45+ (bone marrow derived) GR-1- (non-
neutrophil/ macrophage) CD3- (non T), but one subset 
was CD11b+ (/32 integrin) and the other was CD11b-. 
Ultrastructural examination of class II MHC+ cells re-
vealed the presence of a Langerhans cell-like/ 
indeterminant cell subset with indented nuclei, den-
dritic morphology, active cytoplasm, and dense in-
termediate filaments. Phagolysomes and Birbeck 
granules were not observed in such cells, indicating 
these were distinct from dermal macrophages and 
from classical epidermal Langerhans cells, respec-
tively. Cells with a monocyte/macrophage ultrastruc-
tural appearance were also noted, likely representing 
M urine epidermal Langerhans cells are capable of presenting antigen to resting T cells, initiating primary T-cell responses, and inducing contact hypersensitivity responses in vivo [1]. However, Langerhans cells (LC) are not required to initiate 
contact sensitivity [2]. Indeed, a population of cells in murine der-
mal cell suspensions expressing class II major histocompatibility 
complex (MHC) antigens are also capable of initiating contact hy-
persensitivity responses ill vivo [3], and antigen presentation in vitro 
[4]. Unresolved, however, is t he anatomic position of murine class II 
MHC+ cells in the dermis, whether they are heterogeneous or ho-
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the class II MHC subset expressing CD11b and Ly6c 
(monocyte/ endothelial antigen). Dermal cells in sus-
pension were capable of processing and presenting 
large protein antigens to antigen-specific T-cell hy-
bridomas; dermal cells also induced the syngeneic 
mixed lymphocyte reaction. The dermal antigen-pre-
sentation activities were totally abrogated by removal 
of class II MHC+ cells, but not by removal of CD11b+ 
cells or Ly6c+ cells, indicating that potent antigen-pre-
senting cell activity was restricted to the class II MHC+ 
CD11b- Ly6c- subset (Langerhans cell-like/ inde-
terminant cells). In conclusion, within a complex array 
of dermal leukocytes a murine dermal class II MHC+ 
cell population expressing a Langerhans cell-like/ 
dendritic antigen-presenting cell phenotype and ex-
hibiting potent antigen processing and presenting ac-
tivity can be identified. The positioning of potent 
interstitial dendritic antigen-presenting cells at the in-
terface of the vasculature with the dermal interstitium 
provides rapid access to an antigen-presenting cell as T 
cells first egress into the skin.] Invest DermatolI03:678-
683, 1994 
mogeneous populations (i.e ., a collection of dermal LC, macro-
phages, endothelial cells, and stromal dendrocytes as in humans [5] 
versus a pure population of dermal LC/dendritic antigen-present-
ing cell lineage cells) . In add ition, their ultrastructure and relative 
functional capacity to process and present antigens remain unclear. 
In the dermis of human skin, cells with dendritic or elongate 
morphology ("dermal dendrocytes") [6] appear quite heteroge-
neous. Markers such as FXIlIa [7]. CD36 [8], HLA-DR [9], and 
anti-macrophage antibodies [8 -10] also have indicated that many 
cells assume elongate morphology in the dermis, and that dendritic-
ity does not equate with the more narrowly defined population of 
dendritic immunologic "professional" antigen-presenting cells of 
spleen, blood, lymph nodes, epidermis, and other organs [11]. The 
initial study that clearly distinguished complex subsets in human 
dermis used quantitative triple color flow cytometry of dermal cell 
suspensions and demonstrated that the spectrum of dermal class II 
MHC+ cells included non - bone marrow - derived stromal dendro-
cytes, as well as bone marrow-derived monocyte/macrophage cells 
and a small but potent LC-like interstitial dendritic antigen-pre-
senting cell lineage subset [5]. A distinct subpopulation of class II 
MHC+ dendritic cells has been identified in perivascular human 
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dermis that possesses a m acrophagic phenotype [5,10 ,12,13]. Other 
studies of human skin have indicated the presence of an indetermin-
a te cell Lan gerhans-like derma l population, with similarities to 
Langerhans ce lls based upon COlc and COla expression as well as 
upon ultras tructural features [5 ,14 - 16], and that m ay also represent 
the cutaneous version of interstitial dend ritic antigen-presenting 
cells found in other o rgans [17] . 
In this study, w e defined the morphologic phenotype and func-
tional characteristics of class II MHC+ CD45+ ce lls in murine 
dermis to be that o f the interstitial dendritic antigen-presenting cell 
fami ly re lated to ep idermal Langerhans cells. These characteristics 
were distinct from those of differentiated dermal macrophages . 
Processing oflarge protein antigens and antigen-presentation activ-
ity was restricted to the class II MHC+ population , in particular the 
class II MHC+ C011b- subset (indeterminant, non-macrophage). 
Thus, among dermal cells, a numerically minor but specific and 
potent class II MHC+ subset is responsibl e for antigen processin g 
and presentation function in th e perivascular interstitium. 
MATERIALS AND METHODS 
Antibodics for Phcnotypic Analysis Anti-Iak or anti-lad (mouse) anti-
bodies were obtained from Becton Dickinson. Mountainview, CA. M 1/70, 
a Mac-l (CD11 b) myeloid cell marker, was obtained from Boehringer 
Mannheim Biochemicals, Indianapolis, IN . LC were marked with NLDC-
145 (18) and monocyte macrophagic cells were m3.rkcd with Monts-l Ly6c 
(19) . Endothelial cells were detected with anti - factor VIII - related antigcn 
(Atlantic Antibodies, Scarborough, ME). Unconjugated isotype controls 
were obtained from Sigma Chemical Co., St. Louis, MO and Pharmingen, 
San Diego, CA. Biotin anti-Iak, phycoerythrin (PE) -conjugated rat anti-
CD45; fluorescein isothiocyanate (FITe) - conjugated rat anti-Gr-1; FITC-
conjugated rat anti-CD3; and the respective conjugated isotype controls 
were obtained from Pharmingen. Texas Red -conjugated goat anti-mouse 
IgG was obtained from Cal tag, San Francisco, CA. Ultra avidi n allophyco-
cyanin (APe) was obtained from Lcinco Technologies, Inc., St. Louis, MO. 
Immunofluorcsccncc Staining on Frozcn Scctions or Epidcrmal and 
Dcrmal Sheets Cryostat sections of back skin biopsies from 8 - 12-week 
C3H/HeN and BALB/c mice (C harles River Laboratory, Wilmington, 
MA) were double stained as prcviously described (20) . In other experiments, 
C3H/HeN car epidermis was separated from the dermis, as described (20). 
The epidermal and dermal sheets were incubated with primary antibodies 
(an ti-Iak, NLDC-145 or isotype controls) and visualized with secondary 
antibodies for double immunofluorescence nllcroscopy as preVIOusly de-
scribed (20). 
Four-Color Flow Cytomctry Dermal cell suspensions were prepared as 
described (3) for four-color f1 ow-cytometric analysis. 1 X 106 dermal cells 
were preincubated with mouse IgG2a and rat anti-mouse IgG Fc receptor II 
(2.4G2) to block FcIgG type I and II receptors, respectively, followed by the 
directly conjugated monoclonal antibodies: biotin-conjugated anti-Iak, PE-
conjugated rat anti-CDI1b (Ml /70), PE-conjugated rat anti-CD45 , FITC-
conjugated rat anti- Gr-l, FITC-conjugated rat anti-CD3, and second-step 
incubation with APe. Control tubes were stained with identically conju-
gated isotype control antibodies. Ethidium monoazide (EMA) was added to 
identify dead cells [20,2 1], followed by fixation in 1 % paraformaldehyde. 
Antigen Prcscntation by Dermal Ccll Suspcnsions Dermal cel ls in 
suspension were first incubated with specific or isotype-control antibodies 
followed by absorption of specific subsets onto goat anti-mouse IgG-coated 
magnetic beads (Dynal Inc., Fort Lee, NJ) , as described [20]. rn some experi-
ments, the pellet of absorbed cells and beads was then fixed with 4% glutar-
aldehyde, post-fixed in OsO. with sucrose, dehydrated, infiltrated, and em-
bedded in Epon, as described [20,22) for electron microscopy. 
Antigen-processing and -presentation activity of dermal cells in suspen-
sion were assessed by adding varying concentrations of C3H/ HeN dermal 
cells to 5 X 10' 3A9/6.8 T-cell hybridoma cel ls (recognizes the 46-61 
amino acid peptide fragment of hen egg Iysozome [HEL) when bound by 
[ak) and 1 liM HEL, or BALB/c dermal cells to 2 X 105 8B2 T-cell hybri-
doma cells (recognizes PPD bound by lad) and lOt1g PPD. After 22-24 h of 
culture at 37"C in a 96-well flat-bottom microtiter plate, culture superna-
tant was removed. The amount of interleukin-2 (IL-2) in the supernatant 
was quantitated by adding 1 X 103 HT -2 cells (IL-2 dependent cell line) and 
measuring 3H-thymidine incorporation at 24-32 h. The magnitude and 
sensitivity of the antigen-specific 3A9/HT-2 or 8B2/HT-2 assay is ex-
tremely similar to that of conventional LC stimulating polyclonal splenic T 
cells (not shown). 
Itl vitro syngeneic dermal cell - lymphocyte reactions were performed in 
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Figurc 1. Dermal class II MHC+, factor vrn- and class II MHC-, 
factor vrn+ cclls in frozcn scctions of BALB/c skin. Double-color 
immunofluorescence microscopy reveals class II MHC in a and factor VII! 
staining in b. The CIIrtled solid arrows represents class I! MH C+, fac tor VII!-
cel ls both in the epidermis and dermis; the CIIrved OpCII arrows indicate class I! 
MHC- factor VII!+ vascular cells. Bar, 50 lim. 
flat-bottom microtiter wells. Gamma-i rradiated (2000 rads) C3H/ H eN 
dermal cells were added in varying concentrations to 250,000 responder 
splenic C3H/HeN T cells that had been rigorously depleted of antigen-pre-
senting B cells, monocytes, macrophages, and dendritic cells (20). Dnring 
the last 16-18 h of a 7-d culture, the cells were labeled with 1 IiCi of 
3H-thymidine (20 Ci/mM , ICN Radiochemicals, Irvine, CAl per well. 
RESULTS 
Dermal Perivascular Class II MHC+ Cells Express Monocy-
tic, Langerhans Cell, and Macrophage Markers In the dermis 
ofBALBjc skin , a populatio n of class II MHC+ (Jad+) dendritic cells 
(Fig la, solid arrows) was identified to be distinct from factor VIII + 
endothelial cells (Fig lb, open arrows). Unlike the homogeneous 
composition of class II MHC+ CD11b+ LC in the epidermis of 
C3HjHeN mice (Fig 2a,b) and BALBjc mice (data not shown) , 
dermal perivascular and interstitial dendritic cells comprised three 
Figure 2. Dcrmal class II MHC+, CD11b+ and class II MHC+, 
CDllb- cells in frozcn sections ofC3H/HeN skin. Dual-color immu-
nofluorescence microscopy exhibits CD 11b in a and class II MH C staining 
in b. The upper right and left-most straight solid arrows point to class I! MH C+ 
CD llb+ cells in the epidermis; the lower right straight solid arrow points to 
one in the dermis. The straight opel/ arrow points to a class I! MHC- CD llb+ 
cell. The CIIrtled opel/ arrows represent class II MHC+ CD 11b- cel ls in the 
dermis. Small straigllt arrows delineate the dermal-epidermal junction. Bar, 
100 lim (a and b) . 
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Figure 3. Expression of class n MHC and NLDC-14S in both epider-
mal and dermal sheets of C3H/HeN mice. Epidermal and dermal sheets 
of normal skin were double stained with anti-Ia and NLDC-t4S. Solid 
straight arrows indicate the class II MHC+ (a) and NLDC-t4S+ (b) cells in 
the epidermis; curtJed solid arrows indicate the presence of class II MHC+ (c) 
and NLDC-t4S+ (d) cells in the dermis. The curved ope" arrow points to a 
class II MHC+ (c) and NLDC-t4S- (d) cell in the dermis. Bar, 2S ).lm. 
populations: 1) the majority (> 60%) of class II MHC+ cells ex-
pressed CDl1b; 2) another minor subset expressed only Ia antigens 
(class II MHC+ CD 11 b-), and 3) very few cells expressed only 
CDllb (class II MHC- CD11b+) (Fig 2a,b). 
LC in C3H/HeN epidermal sheets expressed both Ia (Fig 3a) 
and the Langerhans cell- specific marker, NLDC-14S (Fig 3b) 
[18J. Similarly, dendritic cells in C3H/HeN dermal sheets were 
observed to express both Iak (Fig 3c) and NLDC-145 (class II 
MHC+ NLDC-14S+) (Fig 3d), indicating a close lineage relation-
ship to epidermal Langerhans cells. In addition to class II MHC+ 
NLDC-145+ cells, a class II MHC+ NLDC-14S- population was 
present in the dermis (Fig 3d). 
Class II MHC+ Dermal Cells Are Homogenous with Regard 
to CD45 and Heterogeneous with Regard to CDllb Expres-
sion After excluding non-viable (EMA +) dermal cells, dot plots of 
cellular cytoplasmic complexity (90 · light scatter) (Fig 4a, X axis), 
versus APC intensiry (Y axis) clearly revealed a distinct class II 
MHC+ population, which comprised 2.S% of total dermal cells 
isolated (Fig 4a, contour C). The class II MHC+ dermal cells (Fig 
4a, contour C) were electronically selected and examined for their 
CDl1b (macrophage/neutrophil fJ2 integrin), Gr-1 (neutrophil), 
and CD45 (bone marrow-derived) expression by adding isotype 
controls (Fig 4b). PE anti-CD 11 band FITC anti - Gr-1 (Fig 4c), or 
PE anti-CD45 and FlTC anti - Gr-I (Fig 4d). Relative to nonspe-
cific binding of PE and FITC rat IgG on dermal Ia+ cells (Fig 4b), 
display of CDllb intensiry versus GR-1 intensiry reveals two sub-
sets of class II MHC+ dermal cells; one is Ia+ CD11b+ (quadrant I, 
1.7% of total dermal cells isolated), and the other is la+ CDI1 b-
(quadrant 3, 0.7% of total dermal cells isolated). Neither the 
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Figure 4. Ia+ dermal cells are mainly CDllb+GR-l-CD45+. C3H/ 
HeN dermal cell suspensions were quadruple stained with EMA, biotin-
co~ugated mouse anti-Iak , PE-conjugated rat anti-CDllb, and FITC-
conjugated rat anti-Grot or PE-conjugated rat anti-CD4S and FITC rat 
anti-Grot (versus isotype-matched control antibodies) followed by a second 
incubation with ultra avidin allophycocyanin. Dead cells were excluded by 
gating out EMA+ cells. Dermal cell expression of class II MHC is shown in a 
(contour C). Ia+ cells in contour C were then selected for display of isotype 
binding (b), or expression of CDItb, Gr-I, and CD4S (c and d). 
ing not only the lack of neutrophils but also the lack of differen-
tiated myeloid cells [23J within both Ia+ populations. By contrast, 
staining with PE rat anti-CD45 (Fig 4d) revealed a major 
Ia+CD4S+ population (quadrant 1,2.0% of total dermal cells iso-
lated) and a very minor Ia+CD4S- subset that m.ay be artifactual 
(quadrant 3, O.OS% of total dermal cells isolated). Thus, in contrast 
to human dermis [5], there were only rare class II MHC-expressing 
cells in murine dermis that were not bone marrow derived. 
CDllb+ Cells Are Comprised of Class II MHC+ GR-t- Den-
dritic APC/LC/monocytes, Class II MHC- GR-t- Macro-
phagic Cells, and Class II MHC- GR-t+ Neutrophils We 
next viewed the dermal cell population from the point of view of all 
CD11b+ cells (Fig 5, contour D), to characterize the class II MHC-
CD1tb+ cel ls noted by immunofluorescence microscopy (Fig 2). 
Relative to isotype APC and FITC binding to CDl1b+ cells (Fig 
5b) , three populations of CD11b+ dermal cells were identified (Fig 
5c): 1) la+ CD11b+ GR-I- cells in quadrant 1 (dendritic antigen-
presenting cell/LC/monocytes) (1.7% of total dermal cells iso-
lated); 2) la- CDllb+ GR-1- cells in quadrant 3 (differentiated 
macrophages) (0 .3% of total dermal cells isolated); and 3) Ia-
CD11b+ GR-1+ cells in quadrant 4 (neutrophils) (0.3% of total 
dermal cells isolated). All of the Ia+ cells are bone marrow - derived 
(CD4S+) and none of them are of the T-cell lineage (CD3-) or 
granulocyte lineage (GR-l-) (Table I). In addition to the Ia+ bone 
marrow-derived dermal cells, there are both Ia- T cells (CD3+) 
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Figure 5. Heterogeneity of CDllb+ dermal cells. CDll b+ cells were 
selected as above and examined for the expression of Ia and Gr-l. a (contour 
D) indicates the CDl l b+ cells. Expression of la+ COt t b+ Gr-l - , (quadrant 
1) Ia- CDl lb+ Gr-l- (quadrant 3), and Ia- CD ltb+ Gr-l + (quadrant 4) 
subsets is indicated in c respective to the isotype control, in b. 
and Ia- non-T ce lls (CD3- ) that are bone marrow derived (CD45+) 
within the dermis. 
Ultrastructure of Class II MHC + Dermal Cells Dermal cells 
contained in the class MHC+ population absorbed onto goat anti-
mouse IgG immunomagnetic beads had extensive membrane proj-
ects and foldings, an indented nucleus, and an active cytoplasm (Fig 
6). Although many had dense intermediate filaments characteristic 
of epidermal Langerhans cells, Birbeck granules were not observed 
by our method, indicating that they are ei ther absent or not abun-
dant in the class II MHC+ dermal cells. This population appeared 
identical to indeterminate cells of the epidermis. Occasional cells 
with the ultrastructural appearance of non-dendritic monocytic in-
determinate cell s and endothelial cells were also noted (not shown). 
Dermal Cells Are Capable of Processing and Presenting 
Large Protein Antigens Because the ability to process antigen 
and present it to T cells is characteristic of the professional dendritic 
antigen-presenting cell lineage population, we determined whether 
and which cells in dermal cell suspensions could process and present 
large protein anti gens. T-cell hybridoma 3A9/6.8 IL-2 production 
[24] occurred in response to processing and presentation ofHEL by 
I_Ak+ C3H/HeN dermal cells in a dose-related fashion (Fig 7, 
representative experiment, n = 4 experiments). As few as 12,500 
dermal cells (approximately 90 Ia+ CD 11 b- cells at 0 .7% of total 
dermal cell population) were capable of inducing IL-2 production, 
with maximal responses elicited using 100,000 dermal cells. In con-
trast, no IL-2 was produced if dermal cells were combined with 
HEL alone (Fig 7, no 3A9) or 3A9/6.8 cells alone (Fig 7, 0 DCS). 
Dermal cells from BALB/c mice were also capable of processing 
and presenting PPD to the lad-restricted T-cell hybridoma 8B2 (not 
shown), indicating that this phenomenon is not limited to C3H/ 
HeN mice, despite that BALB/c dermis exhibits low NLDC-145 
expression. Thus, freshly isolated dermal antigen-presenting cells 
are in a functional state completely capable of internalizing, pro-
cessing, and presenting large protein antigens. 
Table I. Bone Marrow - Derived Dermal Cell Subsets 
Determined by Flow Cytometry 
Identity 
LC-like antigen-





Mast cel ls, eosh 
Phenotype 
Ia+ COl tb+ Gr-t -
Ia- CD llb+ GR-l -
Ia- COl tb+ GR-t+ 
Ia- CD45+ CD3+ 
la- CD45+ CD3-< 
• Percentage of total dermal cell population. 
• Also potentially includes basophils, B cells, and NK cells. 
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Figure 6. Transmission electron micrograph of class II MHC+ cells 
separated by positive selection on immunomagnetic beads (lower 
left). Cells with abundant membrane, active cytoplasm, and indented nuclei 
predominated. Bar, 1 /1m. 
Antigen-Presenting Cell Activity of Dermal Cells Is Criti-
cally Dependent Upon Class II MHC+ Cells that Lack 
CDllb Dermal cells treated with IgG isotype control fo llowed 
by goat anti-mouse IgG-coated magnetic beads induced significant 
IL-2 production (Fig 8, Ab = IgG). Dermal cells depleted with 
anti-Ia monoclonal antibody resu lted in a > 90% depletion of Ia+ 
cells and a markedly diminished release of IL-2 (Fig 8, Ab = lak, 
representative experiment, n = 3 experiments). By contrast, deple-
tion with anti-CD1 1b (or anti-Ly6c) did not result in depletion of 
HEL antigen presentation (Fig 8), indicating that removal of the 
C D 11 b+ subset of Ia+ cells, although leaving intact the numericall y 
minor CDl1b- Ia+ GR-l- subset (Fig 4c), allowed retention of 
antigen processing and presentation activity. Conversely, the 
CD11b+ la- subset does not appear capable of antigen processing 
and presentation (Fig 8). 
Syngeneic Mixed Lymphocyte Reaction Activity Is Depen-
dent Upon Ia+ Cells To determine w hether dermal cells were 
capable of presenting auto-antigens, a feature more specific for ma-
ture dendritic antigen-presenting cells [25], syngeneic mixed lym-
phocyte reaction experiments were performed. T-cell proliferation, 
measured as 3H-thymidine incorporation, increased from 7,000 
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Figure 7. Dermal cell suspensions (DCS') can process and present 
hen egg lysozyme (HEV) to the lak-restricted T-cell hybridoma 
(3A9/6.83 ). IL-2 production was measured by HT-2 cell proliferation. 
Results expressed as mean ± SEM CPM of tritiated thymidine uptake over 
the last 12 - 16 h of culture. 
CPM using 3,BOO dermal cells to 11,400 CPM using 60,000 dermal 
cells (Fig 9, depleted with IgG isotype control). Depletion of class 
II MHC+ cells using anti-Iak antibody followed by goat anti-mouse 
IgG-coated magnetic beads significantly reduced syngeneic T-cell 
proliferation using both 3,BOO and 60,000 de rmal cells (Fig 9, rep-
resentative experiment, n = 3). 
DISCUSSION 
These data characterize the phenotype, localization, ultrastmcture, 
and functional capabilities of a class II MHC+ potent antigen-pre-
senting population w ithin murine dermis. U ltrastmcturally, cells 
identical to indeterminant cells in the epidermis are contained in the 
class II MHC+ dermal population, in that they have active cyto-
plasm, indented nucleus, and dense intermediate filaments, but lack 
abundant Birbeck granules. The lack of phago-lysosomes confirms 
their distinction from dermal macrophages. The expression of 
DCS' Ab 2 HEL3 3A9' 
10' Sx10' 
10' IgG llJM 5xl0' 
10 ' la K llJM 5xl04 P 
~--------------~ 
10' Mac 1 llJM 5xl04 
10' Monts 1 llJM 5xl0' 
o 3 6 9 12 
CPM X 103 
HT -2 cell proliferation 
Figure 8. Antigen processing and presentation of hen egg lysozyme 
(HEU) by C3H/HeN dermal celh is dependent upon Ia+ cells. Der-
mal cell suspensions (DCS') at 105 per well were mixed with 5 X 104T-cell 
hybridoma cells (3A9/6.84) for 24 h, and IL-2 production assessed as above. 
Dermal cells were treated with either of the following antibodies (Ab2): IgG 
isotype-control, an ti-Iak, anti-CDllb (Mac 1), and anti Monts-1 (Ly6c) 
followed by goat anti-mouse IgG-coated magnetic beads. Results arc ex-
pressed as mean ± SEM CPM of tritiated thymidine uptake. 
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Figure 9. Syngeneic antigen-presenting cell activity of dermal cells 
is dependent upon class II MHC+ cells. C3H/HeN dermal cells (DCS' ) 
were depleted with either IgG isotype control or anti-lak monoclonal anti-
body (Ab2) plus immunomagnetic beads. Various doses of dermal cells were 
mixed with 250,000 C3H/HeN T cells (antigen-presenting cell depleted) 
and cultured for 7 d. Results expressed as mean ± SE (CPM of tritiated 
thymidine uptake over the last 18 h of culture. 
NLDC-145 also indicates a close lineage relationship to epidermal 
Langerhans cells and other members of the specialized "profes-
sional" dendritic antigen-presenting lineage in mice [lB,26] . 
Whether these cells are long-lived, slow-cycling residents of the 
peri vasculature, as are Langerhans cel ls within the epidermis, or 
whether they are in transit from the blood to the epidermis [27,2B] 
or from the epidermis to the regional lymph node [29], cannot be 
ascertained at this time. 
Freshly prepared class II MHC+ CDllb- dermal antigen-
presenting cells are capable of processing and presenting large pro-
tein antigens and do not require further maturation in vitro to 
achieve this activity . This would appear in distinction to epidermal 
Langerhans cells, which under certain conditions require matura-
tion ex vivo to acquire potent antigen-presenting activity [25]. How-
ever, freshly obtained epidermal Langerhans cells are fully capable 
of processing and presenting antigen to the BB2 and 3A9 hybrid-
omas under conditions identical to those used in these experiments 
(not shown). Furthermore, dermal class II MHC+ cells were distinct 
from macrophages and functionally similar to specialized dendritic 
antigen-presenting cells in their potent ability to present self-pep-
tides to syngeneic T cells in the syngeneic mixed lymphocyte reac-
tion [30]. 
Because class II MHC+ cell-depleted dermal cells completely 
lacked antigen-presenting activity, the COIl b+ class II MHC-
population (GR-I- macrophages and GR-I+ granulocytes) appeared 
to have little ro le in the antigen-presenting activity observed in this 
study. Although monocytic cells with limited macrophagic ultra-
structura l features were occasionally observed, typical differentiated 
macrophages were not observed within the class II MHC+ prepara-
tion observed under transmission electron microscopy, indicating 
that most dermal macrophages of normal murine skin indeed ex-
press little or no class II MHC. This is in contrast to human dermis, 
in which typical macrophages are contained in the CDllb+ class II 
MHC+ population [5]. Murine class II MHC+ dermal cells are fur-
ther distinguished from tissue macrophages by their lack of phago-
lysosomes, their similar ultrastructural appearance to epidermal in-
determinate cells, and their expression of NLDC-145 [lB] . 
Based on these results, we propose to classify dermal class II 
MHC+ antigen-presenting cells as Langerhans cell - like interstitial 
dendritic antigen-presenting cells, to indicate their close but inexact 
relationship to epidermal Langerhans cells and dendritic antigen-
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presenting cell lineage cells, and to clearly delineate them from 
dermal macrophages. Both cell types would previously have come 
under the nonspecific broad morphologic term "dermal dendro-
cytes," which has evolved to include a number of cell lineages (not 
all of which are even bone marrow derived) [5] that assume a den-
dritic morphology or express FXIIIa as a result of their location in 
the dermis (mast cells, certain macrophages, certain fibroblasts, 
other stromal cells, etc.) [6,7,9,10,31]. 
In conclusion, the dermis contains a potent class II MHC+ 
CD11b- antigen-presenting cell population that resides in a critical 
anatomic location perivascular to the endothelium. Their expres-
sion of class II MHC and NLDC-145, their potent antigen-process-
ing and -presenting activities, and their lack of ultrastructural and 
phenotypic characteristics of macrophages make it possible to dis-
tinguish them from dermal macrophages . These dermal Langer-
hans cell- like interstitial dendritic antigen-presenting cells are 
most likely important in the initial activation ofT cells upon their 
entry into the skin from the blood, and may be involved in traffick-
ing of antigens between skin and regional lymph nodes [32]. 
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